advanced refractory solid tumors

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

Completed
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Taichung City, Taiwan
  • +3 more
Nov 17, 2022

Advanced Refractory Solid Tumors Trial in China (Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF)

Recruiting
  • Advanced Refractory Solid Tumors
  • Hypofractionated radiotherapy
  • +3 more
  • Beijing, China
  • +15 more
Aug 8, 2022

Advanced Refractory Solid Tumors Trial in Kaohsiung, Tainan (T-1101 (Tosylate))

Recruiting
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Kaohsiung, Taiwan
  • +1 more
Oct 31, 2021

Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in

Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
Aug 31, 2021

Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

Terminated
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Tainan, Taiwan
  • +2 more
Apr 14, 2021

Advanced Refractory Solid Tumors Trial in Kurralta Park (CS1001, Regorafenib)

Recruiting
  • Advanced Refractory Solid Tumors
  • Kurralta Park, South Australia, Australia
    Ashford Cancer Centre Research
Sep 23, 2020

Advanced Refractory Solid Tumors Trial in Goyang-si (NOV120401)

Unknown status
  • Advanced Refractory Solid Tumors
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Aug 13, 2015

Advanced Refractory Solid Tumors Trial in India, United States (PL225B)

Suspended
  • Advanced Refractory Solid Tumors
  • Los Angeles, California
  • +4 more
Sep 26, 2014

Advanced Refractory Solid Tumors Trial in India, United States (P7170)

Suspended
  • Advanced Refractory Solid Tumors
  • Los Angeles, California
  • +3 more
Sep 26, 2014